Literature DB >> 10089479

Separation and crystallization of T = 3 and T = 4 icosahedral complexes of the hepatitis B virus core protein.

A Zlotnick1, I Palmer, J D Kaufman, S J Stahl, A C Steven, P T Wingfield.   

Abstract

The icosahedral nucleocapsid of human hepatitis B virus is a homopolymer of the dimeric capsid protein also known as hepatitis B core antigen or HBcAg. Purified capsid protein obtained from an Escherichia coli expression system was reassembled into a mixture of T = 3 and T = 4 icosahedral particles consisting of 90 and 120 dimers, respectively. The two types of capsid were separated on a preparative scale by centrifugation through a sucrose gradient. In addition to this heterogeneity, the capsid protein has three cysteines, one of which has a great propensity for forming disulfide bonds between the two subunits, forming a dimer. To eliminate heterogeneity arising from oxidation, alanines were substituted for the cysteines. T = 3 and T = 4 capsids crystallized under similar conditions. Crystals of T = 3 capsids diffracted to approximately 8 A resolution; crystals of T = 4 capsids diffracted to 4 A resolution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089479     DOI: 10.1107/s090744499801350x

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  21 in total

1.  Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1.

Authors:  Christina R Bourne; M G Finn; Adam Zlotnick
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 2.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Competition between Normative and Drug-Induced Virus Self-Assembly Observed with Single-Particle Methods.

Authors:  Panagiotis Kondylis; Christopher J Schlicksup; Nicholas E Brunk; Jinsheng Zhou; Adam Zlotnick; Stephen C Jacobson
Journal:  J Am Chem Soc       Date:  2018-12-31       Impact factor: 15.419

4.  The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription.

Authors:  Zhenning Tan; Karolyn Pionek; Nuruddin Unchwaniwala; Megan L Maguire; Daniel D Loeb; Adam Zlotnick
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 5.  The Structural Biology of Hepatitis B Virus: Form and Function.

Authors:  Balasubramanian Venkatakrishnan; Adam Zlotnick
Journal:  Annu Rev Virol       Date:  2016-08-01       Impact factor: 10.431

Review 6.  Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

Authors:  Maria Yanqing Chen; Susan S Butler; Weitong Chen; Junghae Suh
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-11-08

7.  Characterization of hepatitis B virus capsids by resistive-pulse sensing.

Authors:  Kaimeng Zhou; Lichun Li; Zhenning Tan; Adam Zlotnick; Stephen C Jacobson
Journal:  J Am Chem Soc       Date:  2011-01-25       Impact factor: 15.419

8.  Expression, purification, crystallization and preliminary crystallographic analysis of hepatitis B virus core protein dimerized via a peptide linker containing an EGFP insertion.

Authors:  Masaki Kikuchi; Shinichiro Iwabuchi; Tatsuhiko Kikkou; Keiichi Noguchi; Masafumi Odaka; Masafumi Yohda; Masaaki Kawata; Chikara Sato; Osamu Matsumoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

9.  Expression, purification, crystallization and preliminary X-ray crystallographic studies of hepatitis B virus core fusion protein corresponding to octahedral particles.

Authors:  Masaki Kikuchi; Shinichiro Iwabuchi; Tatsuhiko Kikkou; Keiichi Noguchi; Masafumi Odaka; Masafumi Yohda; Masaaki Kawata; Chikara Sato; Osamu Matsumoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-31

10.  Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure.

Authors:  Sarah P Katen; Zhenning Tan; Srinivas Reddy Chirapu; M G Finn; Adam Zlotnick
Journal:  Structure       Date:  2013-07-18       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.